Navigation Links
Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
Date:2/17/2011

FRANKLIN, Mass., Feb. 17, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced that development of the commercially ready Symphony tCGM System is ahead of schedule.  The company said that the system will be ready for demonstration in the second quarter and it will be used in a clinical trial shortly thereafter, replacing the prototype used in earlier clinical trials.  

Echo said it anticipates that upon completion of the development work no further changes will be made to the Symphony tCGM System, and that the device will be the one used for sale, subject to positive clinical studies and FDA market clearance of the product.  The addressable market for needle-free, continuous wireless glucose monitoring in the hospital critical care setting exceeds $1 billion annually and the global glucose monitoring market exceeds $12 billion annually.

"With the successful completion of our recent financing we now have sufficient capital to accelerate the product development work of our Symphony tCGM System," said Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "We are now prepared to complete our final development work and clinical validation.  This next generation Symphony device incorporates substantial improvements beyond the prototype used in earlier studies and we look forward to validating those improvements in clinical testing."  

The Symphony tCGM System incorporates Echo's proprietary Prelude SkinPrep System, with a noninvasive wireless biosensor and a wireless monitor or handheld device for needle-free, continuous monitoring of glucose levels.  

About Echo TherapeuticsEc
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
2. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
3. Echo Therapeutics Announces Appointments to Board of Directors
4. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
5. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
6. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
7. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
8. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
9. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
10. DSM and NKT Therapeutics Sign Contract for Lead Product Development and Manufacture
11. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015   InspireMD, Inc. (NYSE MKT: ... systems, announced today that it will release its full financial ... Monday, May 11 th before the open, followed by ... financial results and business outlook. Participants should call ... 542-4135 (International) and request the InspireMD call. A live webcast ...
(Date:5/5/2015)... Ill. , May 5, 2015 ... diagnostic testing equipment and information systems technology, today ... information systems company. This partnership allows Sysmex and ... and interfacing solution for physician offices and clinics ... directly to Electronic Medical Record (EMR) systems. ...
(Date:5/5/2015)... 5, 2015 GW Pharmaceuticals plc (Nasdaq: ... biopharmaceutical company focused on discovering, developing and commercializing ... announced today the closing of the previously announced ... of 1,600,000 American Depositary Shares (ADSs) at a ... of approximately $179.2 million (before deducting underwriting discount, ...
Breaking Medicine Technology:InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... , CVS/pharmacy and the New York State Fraternal Order of ... Outreach yet , PORT JERVIS, N.Y., Dec. 17 On ... of Police and dozens of volunteers came together at Easter ... Jervis, to distribute toys, coats and food to families in ...
... , LITTLE FALLS, N.J., Dec. 17 CANTEL MEDICAL ... Board of Directors intends to pay, for the first time, a ... share annually, on the Company,s common stock. The Board declared the ... to be paid on January 29, 2010 to shareholders of record ...
Cached Medicine Technology:CVS/pharmacy and the New York State Fraternal Order of Police Help Families in Port Jervis Have a Merry and Memorable Holiday Season 2Cantel Medical Authorizes Semiannual Dividend 2
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 With ProPoint: ... all within Final Cut Pro X . With ... within 3D space to further more customize each preset all ... users are given up to 90 fully customizable effect presets ... boxes, circles, curved arrows, straight arrows, underlines, and more. ...
(Date:5/5/2015)... Cosmetic Dentist, Arthur Glosman released a luxury line of advanced ... offices of Arthur Glosman DDS, 450 N Roxbury Drive Suite ... store . “I wanted to be one of the first ... with a luxurious collection of products designed to make you ... Glosman’s Advanced Dental Health + Beauty™ products use a potent ...
(Date:5/5/2015)... New Jersey (PRWEB) May 05, 2015 ... has maintained its strong and secure credit rating of ... of Horizon BCBSNJ’s financials last week, the Wall Street ... adequacy” and “leading market position” in determining the rating ... of mind is one of our top priorities, so ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
Breaking Medicine News(10 mins):Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3
... sensitive tooth at some point of their life. A visit to ... or 'you brush in a hard way, so your teeth are ... out with a solution that could make sensitive teeth a bad ... out the dentinal tubules which transmit painful signals to the pulp, ...
... to fund a study which helps to understand the ... to breast cancer patients to ease the pain they ... study is to be carried out by Researchers from ... the three complementary therapy methods reflexology, guided imagery and ...
... one of the most common breathing problems encountered by ... has been a considerable increase in the incidence of ... been estimated that nearly 196,000 children are hospitalized in ... considerable amount is being spent on the health issue ...
... loss of motor function in a part due to ... Lateral Sclerosis// is a form of motor neuron disease ... incapable of even the slightest movements such as blinking. ... ,The new headband that has been developed by Japanese ...
... year India’s Health care has been in constant limelight ... the healthcare system in India came to focus after ... the City leaving thousands homeless, many orphaned and a ... worked quickly and effectively with the people providing immediate ...
... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
Cached Medicine News:Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... placement to stent the ureter ... continent urinary diversions. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... remain indwelling more than six ...
... The Bard® C-Max™ Cutting Loop is ... smooth tissue cut. The cutting loops are ... standard. The tungsten wire-cutting loop is hand ... process. These electrodes are made to exacting ...
Medicine Products: